Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
Loading...
0:00 / 0:00
Podjoint Logo
US
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/e0/16/a7/e016a72a-3255-8e4c-804e-6855e685a274/mza_18057399343301114994.jpg/600x600bb.jpg
BioSpace
BioSpace
158 episodes
2 days ago
Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.
Show more...
Life Sciences
Science
RSS
All content for BioSpace is the property of BioSpace and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.
Show more...
Life Sciences
Science
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/39510587/39510587-1754337759047-fd460808ff1e3.jpg
From Chat Bots to World Order: The Race for the 21st Century's Operating System
BioSpace
20 minutes 12 seconds
2 weeks ago
From Chat Bots to World Order: The Race for the 21st Century's Operating System

In this thought-provoking episode, Cresset Group’s CSO, Mark Mackey, and VP of AI, Mutlu Dogruel, dissect the emerging geopolitical battle for AI supremacy, revealing how China's DeepSeek model fundamentally disrupted the AI landscape by achieving GPT-4 level performance for just $6 million versus OpenAI's reported $100+ million investment.

The discussion exposes a critical divide in global AI governance: Europe's "regulatory fortress" approach with the AI Act creates strict but vague rules that leave companies navigating a complex maze, while the US employs a "Wild West" philosophy of sector-specific oversight and red-teaming strategies. In the race for global AI dominance, China is leaping ahead of the US and the EU.

This episode is presented in partnership with Cresset.


Host

⁠⁠⁠⁠⁠⁠⁠Lori Ellis⁠⁠⁠⁠⁠⁠⁠, Head of Insights, BioSpace


Guests

Mutlu Dogruel, VP of AI, Cresset

Mark Mackey, CSO, Cresset


Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.

BioSpace
Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.